CSL Behring
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies (PIDD); hereditary angioedema; inherited respiratory disease; and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn. CSL Behring operates the plasma collection network, CSL Plasma.
Wikipage disambiguates
primaryTopic
CSL Behring
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. Its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von Willebrand Disease; primary immune deficiencies (PIDD); hereditary angioedema; inherited respiratory disease; and neurological disorders in certain markets. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn. CSL Behring operates the plasma collection network, CSL Plasma.
has abstract
CSL Behring is a biopharmaceut ...... ollection network, CSL Plasma.
@en
CSL Behring mit Sitz in King o ...... rika sowie der mittlere Osten.
@de
location
number of employees
Link from a Wikipage to an external page
Wikipage page ID
12,496,027
Wikipage revision ID
743,226,306
industry
key people
Paul Perreault, CEO and Managing Director of CSL Limited
sector
subject
hypernym
comment
CSL Behring is a biopharmaceut ...... ollection network, CSL Plasma.
@en
CSL Behring mit Sitz in King o ...... Plasmaprodukten spezialisiert.
@de
label
CSL Behring
@de
CSL Behring
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
CSL Behring LLC
@en